HSTMHealthcare · Health Information ServicesThe 5 Wall Street analysts covering HealthStream, Inc. hold a median 12-month price target of $35 — +18.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 94 of 100 as at 3 Sept 2026 — among the strongest tenth. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores HealthStream, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (93): The share price has been relatively steady.
Momentum (53): The shares have been drifting down relative to others.
Size (46): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on HSTM, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +18.2% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 21 July 2026 | Canaccord Genuity | Maintains | Hold | $24 → $27 |
| 6 May 2026 | Canaccord Genuity | Maintains | Hold | — |
| 6 May 2026 | Canaccord Genuity | Maintains | Hold | $21 → $24 |
| 17 Dec 2025 | Canaccord Genuity | Maintains | Hold | — |
| 7 Aug 2025 | Canaccord Genuity | Maintains | Hold | — |
| 15 May 2025 | Canaccord Genuity | Maintains | Hold | — |
| 26 Feb 2025 | Canaccord Genuity | Maintains | Hold | — |
| 6 Feb 2025 | JMP Securities | Reiterates | Market Perform | — |
| 23 Oct 2024 | Barclays | Maintains | Overweight | — |
| 23 Oct 2024 | Canaccord Genuity | Maintains | Hold | — |
| 24 July 2024 | Canaccord Genuity | Maintains | Hold | — |
| 6 Dec 2023 | JMP Securities | Initiates | Market Perform | — |
| 22 Feb 2023 | Canaccord Genuity | Maintains | Hold | — |
| 28 Apr 2021 | Canaccord Genuity | Maintains | Hold | — |
| 28 Oct 2020 | Canaccord Genuity | Maintains | Hold | — |
| 20 Dec 2019 | Raymond James | Initiates | Market Perform | — |
| 11 July 2018 | Barrington Research | Downgrade | Market Perform | — |
| 14 June 2018 | Baird | Downgrade | Neutral | — |
| 25 Oct 2017 | Baird | Maintains | Outperform | — |
| 25 Oct 2017 | Needham | Downgrade | Hold | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HSTM appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Sept 2026, HealthStream, Inc. returned +4.1% against +20.0% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 18% of US stocks
Cheaper than 45% of US stocks
Cheaper than 40% of US stocks
Cheaper than 18% of US stocks
Higher than 58% of US stocks
Higher than 62% of US stocks
Higher than 79% of US stocks
Higher than 64% of US stocks
Higher than 64% of US stocks
Higher than 55% of US stocks
Higher than 66% of US stocks
Higher than 9% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
HealthStream, Inc. has a market value of $869.6M and an enterprise value of $816.3M.
Revenue in the twelve months to 30 June 2026: $321.1M. The latest quarter grew 12.5% year on year.
Net income over the same four quarters: $21.2M, a 6.6% net margin.
Diluted earnings per share, trailing twelve months: $0.72.
Free cash flow in the twelve months to 30 June 2026: $41.6M, after $28.2M of capital spending.
HealthStream, Inc. spent $21.2M on share buybacks and $3.9M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 41.3×; forward P/E: 33.6× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.47%, paying out 18% of earnings.
HealthStream, Inc. employs 1,139 people — $282K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own HealthStream, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Humana Healthy Horizons in Indiana announced a collaboration with HealthStream aimed at expanding and strengthening the home care workforce.
Why it matters — The collaboration signals a new partnership for HealthStream in the home care segment, which could broaden its workforce development reach.
HealthStream, Inc. held its Q2 2026 earnings call, and a transcript of the event was published by Seeking Alpha.
Why it matters — An earnings call transcript provides direct insight into the company's recent financial performance and management's commentary on operations.
HealthStream reported record second-quarter revenue and adjusted EBITDA for 2026, driven by growth in core subscription products, contributions from recent acquisitions, and a one-time revenue catch-up tied to customer cost savings. The company raised its full-year revenue and adjusted EBITDA outlook while modestly lowering its net-income guidance as it increases investment in growth initiatives.
Why it matters — A HealthStream watcher would care because the raised full-year revenue and adjusted EBITDA outlook signals continued momentum, while the modest cut to net-income guidance reflects the company's deliberate reinvestment in growth.
HealthStream reported second-quarter earnings of $0.23 per share, topping the Zacks Consensus Estimate of $0.17 per share and up from $0.18 per share in the same period a year ago, with revenues also exceeding expectations.
Why it matters — The earnings beat and year-over-year profit growth indicate a stronger-than-expected quarter for HealthStream.
HealthStream reported second quarter 2026 revenue of $83.7 million (up 12.5% year-over-year) and operating income of $8.3 million (up 41.4% year-over-year), both setting company records.
Why it matters — The results show acceleration in both top-line growth and profitability for HealthStream's core clinical workforce solutions business.
The 5 Wall Street analysts covering HealthStream, Inc. have a median 12-month price target of $35, with estimates ranging from $29 to $40. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 5 analysts covering HealthStream, Inc., 2 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks HealthStream, Inc. 94 out of 100 across roughly 4,600 US stocks as at 3 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Sept 2026, HealthStream, Inc. ranks 94 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (93 of 100).
No one can know that. What the data says: the median 12-month target from 5 analysts implies +18.2% from the last close, and Ticker Nerd's factor model ranks HealthStream, Inc. 94 out of 100 as at 3 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering HealthStream, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HSTM are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $29 to $40 over the next 12 months.
HealthStream, Inc. returned +4.1% over the 12 months to 4 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
HealthStream Inc. is a healthcare technology company that provides software-as-a-service solutions for healthcare organizations in the United States.
The most recent item we track (Business Wire, 11 Aug 2026): "Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce". Humana Healthy Horizons in Indiana announced a collaboration with HealthStream aimed at expanding and strengthening the home care workforce.
HealthStream Inc. is a healthcare technology company that provides software-as-a-service solutions for healthcare organizations in the United States. Its platform supports workforce development, learning management, credentialing, privileging, scheduling, and performance management, helping hospitals and care providers manage clinical staff more efficiently. HealthStream’s offerings also include provider enrollment and simulation-based education tools, along with modules designed to improve competency assessment and talent management across healthcare teams. The company serves hospitals, health systems, and other care delivery organizations that need integrated tools to train employees, maintain compliance, and coordinate workforce operations. HealthStream Inc. plays an important role in the healthcare information services market by connecting training, credentialing, and workforce administration within a single digital environment.
CEO Mr. Robert A. Frist Jr. · 1,139 employees · United States · https://www.healthstream.com
